L9: Opioid receptor antagonist

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/22

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:19 PM on 9/9/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

23 Terms

1
New cards

Objectives

  1. Discuss the mechanism behind opioid addiction

  2. Discuss partial and mixed agonist, and antagonist

  3. Discuss nonsteroidal anti-Inflammatory drugs and nonopioid analgesics


2
New cards

Tramadol

  1. MOA

  2. What does it use COMBO with?

  3. Therapeutic Action


  1. Weak, atypical mu-opioid receptor agonist

    1. Inhibit reuptake of serotonin and NE

  2. In combination with acetaminophen improves its analgesic efficacy

  3. Less adverse effects, no GI bleeding


3
New cards

Levorphanol

  1. MOA

  2. Uses to treat


Binds to opioid receptors, NMDA antagonist, SNRI

Used to treat moderate to severe pain


4
New cards

Partial and mixed agonist Drugs

Nalbuphine

5
New cards

Nalbuphine

  1. MOA

  2. Action

  3. Ceiling effect


  1. Kappa-agonists, weak antagonist at µ and δ receptors

  2. Used to relieve moderate pain

    1. Given with general anesthesia before surgery

    2. Reverse the pruritus induced by neuraxial opioid administration

  3. A ceiling effect for respiratory depression


6
New cards

Buprenorphine

  1. MOA

  2. Therapeutic Action

  3. Withdrawal?


  1. Partial agonist at the µ receptor → more potent than morphine

  2. Opioid addiction treatment, and opioid detoxification

  3. Withdrawal symptoms - less severe and shorter duration


7
New cards

What is used for opioid detoxicfication?

Buprenorphine alone


8
New cards

Drugs for opioid dependence

  • Formulation and

  • DUR

  • Effect?


Sabutex: Buprenorphine alone


Saboxone: Buprenorphine and naloxone (naloxone was added to prevent the abuse of buprenorphine via IV administration)

  • Sublingual, parenteral, transderma

  • Llong duration of action

  • Reduced Euphoria, respiratory depression


9
New cards

Opioid Addiction- Mechanism

GABA – inhibits brain reward pathway

Opioids inhibits GABA action – Activate reward Pathway

10
New cards

Naloxone

  • What kind of receptor?

  • MOA

  • Overdose


  • Opioid receptor Antagonist

  • Rapidly reverse the effect of µ -receptor agonist

  • Reverse the coma, and respiratory depression of opioid overdose


11
New cards

Nasal Spray- Narcan → How does it work?

  • Reverse the effects of high levels of opioids

  • Reverse deadly overdoses


12
New cards

Naltrexone

  1. Class?

  2. Dosage

  3. Duration of action?

  4. ADE


  1. Opioid receptor antagonist (reduce acute dopamine release at nucleus accumbens)

  2. A single oral dose of naltrexone blocks the effect of injected heroin for up to 48hrs

  3. Longer duration of action → XR formulation

  4. Lead to hepatotoxiciy


13
New cards

Opioid Crisis-treatment options → name 3

  1. Methadone maintenance therapy

  2. Buprenorphine maintenance therapy

  3. Naltrexone therapy - extended-release naltrexone (Vivitrol®)


14
New cards

Lofexidine

  • USE

  • MOA


  • Long-term treatment plan for managing opioid use disorder

  • α2 -adrenergic receptor agonist

  • Reduces the release of NE and suppresses sympathetic nervous system


15
New cards

Ketamine

  1. Class

  2. MOA

  3. USE

  4. Risk


  1. NMDA receptor antagonist

  2. Inhibits NMDA receptor

    1. induction and maintenance of central sensitization

  3. Used for acute severe pain

  4. Minimize the risk of respiratory depression


16
New cards

Name 2 types of Analgesics

  1. Orphenadrine citrate: orphenadrine citrate, aspirin, and caffeine

  2. Dextromethorphan

    1. antitussive (cough suppressant) drug

    2. reduce chronic pain symptoms and postoperative pain

    3. high dose required for analgesia

Antiepileptic drugs : gabapentin, pregabalin, lamotrigine and carbamazepine

Adrenergic agonist: Clonidine- agonist to alpha 2- receptors

17
New cards

Analgesics- Antidepressants

  1. Tricyclic antidepressants- blocking sodium channels

    1. Amitriptyline, Nortryptyline Imipramine

  2. SNRIs- used in the treatment of Neuropathic pain and fibromyalgia

    1. venlafaxine

    2. duloxetine

    3. Milnacipran

  3. SSRIs least effective


18
New cards

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

  • MOA

  • PK


  1. Inhibition of cyclooxygenases enzyme activity (COX-1 and COX-2)

    1. Inhibition of prostaglandin biosynthesis

  2. NSAIDs decrease the recruitment of leukocytes AND cross BBB (inhibit prostaglandin generation)


19
New cards

4 major classes of NSAIDS

  1. Indole acetic acid derivatives (indomethacin)

  2. Pyrrole acetic acid derivatives (diclofenac and ketorolac)

  3. Propionic acid derivatives (ibuprofen) benzothiazines (piroxicam)

  4. COX-2 selective inhibitors (Celecoxib, rofecoxib and valdecoxib)

Non-NSAID - acetaminophen

20
New cards

Indole acetic acid derivatives

  1. Drugs

  2. Therapeutic Action

  3. Use


  1. Indomethacin, Sulindac, Etodolac

  2. To treat mild to moderate pain

  3. Indomethacin- arthritis, gout, ankylosing spondylitis

  4. Sulindac- Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis:

  5. Etodolac- rheumatoid arthritis, osteoarthritis


21
New cards

Pyrrole acetic acid derivatives

  1. Drugs

  2. Use

  3. ADE


  1. Diclofenac, Ketorolac

  2. Diclofenac – arthritis, postoperative pain - more potent than indomethacin and naproxen

  3. Ketorolac - oral or parenteral- for short term pain control - used in post surgical patients

  4. Stevens-Johnson syndrome, GI bleeding


22
New cards

Acetaminophen

  1. MOA

  2. Therapuetic Action

  3. MOA

  4. ADE

  5. Antidote


  1. Inhibition of prostaglandin synthesis weak inhibitor of COX-1 and COX-2 - inhibit COX-3 (cyclooxygenase enzyme expressed selectively in the brain)

  2. Analgesic, antipyretics, no anti-inflammatory properties

  3. p-aminophenol → Narachidonoylphenolamine (AM404)

    1. Interacting with endocannabinoid and TRPV1 receptor

  4. Hepatotoxic

  5. Acetylcysteine replenishes glutathione supply to liver → Toxic NAPQI: Normal breakdown of high-dose acetaminophen creates a dangerous waste product called NAPQI. → NAPQI is inactivated by conjugation with glutathione


23
New cards

WHO-3 Step Analgesic pain ladder